Wednesday, August 5, 2020

Lupin launches COVID-19 drug Favipiravir in India at Rs 49 per tablet

Lupin launches COVID-19 drug Favipiravir in India at Rs 49 per tablet Favipiravir has received authorisation from the Drug Controller General of India (DCGI) for emergency use, Lupin said in a regulatory filing.

from Moneycontrol Business News https://ift.tt/33rS6b3

No comments:

Post a Comment

Apollo Micro Systems shares surge 15% following Rs 25 cr order wins from DRDO, other defence PSUs

Apollo Micro Systems shares saw a significant rise. The company secured orders worth Rs 25.12 crores from DRDO and Defence PSUs. This news b...